Characteristics and outcomes of patients with unresected early-stage non-small cell lung cancer

Southern Medical Journal

Volumn 95, Issue 10, 2002, Pages 1149-1152

  Kyasa, Mohammad J ^a   Jazieh, Abdul R ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; PACLITAXEL;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BRONCHOSCOPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; SPUTUM CYTODIAGNOSIS; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

EID: 0036773895     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200295100-00008     Document Type: Article

References (23)

1. Greenlee RT, Hill-Harmon MB, Murray T, et al: Cancer statistics, 2001. CA Cancer J Clin 2001; 50:15-36
2. Flehinger BJ, Kimmel M, Melamed MR: The effect of surgical treatment on survival from early lung cancer: Implication for screening. Chest 1992; 101:1013-1018
3. Read RC, Shaefer RC, North N, et al: Diameter, cell type, and survival in stage I primary non-small cell lung cancer. Arch Surg 1988; 123:446-449
4. Martini N, Burt ME, Bains MS, et al: Survival after resection of stage II non-small cell lung cancer. Ann Thorac Surg 1992; 54:460-465
5. Pairolero PC, William DE, Bergstralh EJ, et al: Postsurgical stage I bronchogenic carcinoma: Morbid implications of recurrent disease. Ann Thorac Surg 1984; 34:331-338
6. Bach PB, Cramer LD, Warren JL, et al: Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999; 341:1198-1205
7. Greenwald HP, Polissar NL, Borgatt EF, et al: Social factors, treatment, and survival in early-stage non-small cell lung cancer. Am J Public Health 1998; 88:1681-1684
8. Polednak AP: Racial differences in the treatment of earlystage lung cancer. N Engl J Med 2000; 342:517-518
9. Van Rens MT, della Riviere AB, Elbers HR, et al: Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 2000; 117:374-379
10. Kaskowitz L, Graham MV, Emami B, et al: Radaiation therapy alone for stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1993; 27:517-523
11. Graham MV, Purdy JA, Emami B, et al: Preliminary results of a prospective trial using three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 1995; 33:993-1000
12. Silby GS, Jamieson TA, Marks LB, et al: Radiotherapy alone for medically inoperable stage I non-small cell lung cancer: The Duke experience. Int J Radiat Oncol Biol Phys 1998; 40:149-154
13. Bush DA, Slater JD, Bonnet R, et al: Proton-beam radiotherapy for early stage lung cancer. Chest 1999; 116:1313-1319.
14. Hayakawa K, Mitsuhashi N, Saito Y, et al: Limited field radiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 1999; 26:137-142
15. McKenna RJ, Wolf RK, Brenner M, et al: Is lobectomy by video-assisted thoracic surgery an adequate cancer operation? Ann Thorac Surg 1998; 66:1903-1908
16. Kaga K, Park J, Nishiumi N, et al: Usefulness of video-assisted thoracic surgery (two windows method) in the treatment of lung cancer for elderly patients. J Cardiovasc Surg 1999; 40:721-723
17. Jaklitsch MT, Bueno R, Swanson SJ, et al: New surgical options for elderly lung cancer patients. Chest 1999; 116(6 suppl):480S-485S
18. Sugi K, Kaneda Y, Esato K: Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage LA lung cancer. World J Surg 2000; 24:27-30
19. McKenna RJ, Fischel RJ, Brenner M, et al: Combined operations for lung volume reduction surgery and lung cancer. Chest 1996; 110:885-888
20. DeMeester SR, Patterson GA, Saundareson RS, et al: Lobectomy combined with volume reduction for patients with lung cancer and advanced emphysema. J Thorac Cardiovasc Surg 1998; 115:681-688
21. Martel MK, Strawderman M, Hazuka MB, et al: Volume and dose parameters for survival of non-small cell lung cancer. Radiother Oncol 1997; 44:23-29.
22. Vanuytsel LJ, Vansteenkiste JF, Stroobant SG, et al: The impact of (18) F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on radiation treatment volumes in patients with non-small cell lung cancer. Radiother Oncol 2000; 55:317-324
23. Choi N, Baumann M, Flentji M, et al: Predictive factors in radiotherapy for non-small cell lung cancer: Present status. Lung Cancer 2001; 31:43-56